First patients take new pill aimed at starving cancer cells
NCT ID NCT05055609
Summary
This is the first study in people testing a new oral medication called TRE-515 for advanced solid tumors that have stopped responding to standard treatments. The main goal is to find the highest safe daily dose and understand how the drug moves through the body. Researchers will also look for early signs that the drug might help slow or stop tumor growth in these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Carolina BioOncology Institute
RECRUITINGHuntersville, North Carolina, 28078, United States
Contact
Contact Phone: •••-•••-••••
-
UCLA
RECRUITINGSanta Monica, California, 90404, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.